Gilder Gagnon Howe & Co’s CME Group CME Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-23,148	Closed	-$6.84M	–	280
2026 Q1	$6.84M	Buy	+23,148	New	+$6.88M	0.08%	130

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Gilder Gagnon Howe & Co's CME Position: Q2 2026 in Review

Gilder Gagnon Howe & Co sold out of CME Group (CME) in Q2 2026, closing a stake of 23,148 shares — an estimated $6.84M sold.

Gilder Gagnon Howe & Co first reported a position in CME in Q1 2026 and held it in 1 quarter. The position peaked at $6.84M in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Gilder Gagnon Howe & Co reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 23,148 CME Group shares in Q2 2026, an estimated $6.84M.
Gilder Gagnon Howe & Co first reported a position in CME Group in Q1 2026 and held it in 1 quarter.
Gilder Gagnon Howe & Co's CME Group position peaked at $6.84M in Q1 2026.
1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2026, filed 14 Aug 2026.